CCI to investigate Swiss drugmaker Roche over breast cancer biosimilar

— April 25, 2017 comments off

CCI’s action is in response to a complaint filed by Mylan and Biocon, who have together developed biosimilar version of Roche’s blockbuster drug for breast cancer.